Chronic Kidney Disease
Understanding Chronic Kidney Disease & Emerging Regenerative Approaches
Chronic kidney disease (CKD) is a long-term condition in which the kidneys gradually lose their ability to filter waste and excess fluid from the blood. Common causes include diabetes, high blood pressure and autoimmune conditions such as lupus.
Alongside established treatments that slow progression, researchers are investigating whether mesenchymal stem cells (MSCs) can reduce kidney inflammation and scarring. Trials are mostly small and early-phase, and none has shown that cell therapy reverses established kidney damage.
Why Chronic Kidney Disease Treatment Matters
Chronic kidney disease affects a large proportion of adults worldwide and often progresses silently for years. As kidney function declines, it can lead to fatigue, fluid retention, heart disease and, eventually, kidney failure.
Current treatments focus on controlling blood pressure and blood sugar, protecting remaining kidney function and preparing for dialysis or transplantation when needed.
Because lost kidney tissue does not regrow, researchers are exploring whether regenerative approaches could slow damage or support the kidney's own repair processes.
Understanding Chronic Kidney Disease & Regenerative Medicine
In many forms of CKD, ongoing inflammation leads to fibrosis, the build-up of scar tissue that replaces working kidney structures. This process drives the gradual loss of kidney function.
MSCs are being studied for their anti-inflammatory and anti-fibrotic effects in diabetic kidney disease, lupus nephritis and other forms of CKD. Most studies so far have been small and focused on safety.
In kidney transplantation, the most promising research is on whether MSCs can help reduce rejection and the need for long-term immunosuppressive medication.
At a Glance
- Gradual, long-term loss of kidney function
- Common causes include diabetes, high blood pressure and lupus
- Inflammation and scarring drive progression
- Established treatments aim to slow decline
- MSCs are being studied for anti-inflammatory and anti-fibrotic effects
- Trials are mostly small and early-phase
- No therapy has shown reversal of established damage
- Transplant research focuses on reducing rejection
How it works
How Regenerative Medicine Is Being Studied for Chronic Kidney Disease
Researchers are investigating whether MSCs can change the inflammatory and scarring processes that damage kidney tissue over time.
Studies measure safety, kidney function markers such as eGFR and protein in the urine, and how these change over months to years.
01
Reducing Kidney Inflammation
MSCs release signalling molecules that are being studied for their ability to calm inflammation within the kidney.
02
Limiting Fibrosis
Researchers are examining whether cell-based approaches can slow the build-up of scar tissue that replaces working kidney structures.
03
Supporting Kidney Cells
Studies are exploring whether MSCs can help protect the kidney's filtering and tubular cells from further injury.
05
Supporting Transplant Outcomes
Transplant research is investigating whether MSCs can reduce rejection and allow lower doses of immunosuppressive medication.
04
Modulating Autoimmune Activity
In lupus nephritis, researchers are studying whether MSCs can help regulate the immune response that attacks the kidneys.
06
Building Clinical Evidence
Larger and longer trials are needed to confirm whether any effect on kidney function is meaningful and lasting.
Visual flow
Chronic Kidney Disease
Inflammation and scarring reduce kidney function
Specialist Review
Kidney function, cause and medical history assessed
Personalised Approach
Evidence-led discussion alongside established care
Who May Consider Chronic Kidney Disease Treatment?
Chronic kidney disease varies widely in its cause, stage and rate of progression. Treatment decisions depend on kidney function, underlying conditions, current medication and overall health.
People who may seek specialist information about kidney disease and emerging regenerative approaches include:
People Living With Chronic Kidney Disease
Individuals with a confirmed diagnosis who want to understand current care and emerging research.
People With Diabetic Kidney Disease or Lupus Nephritis
Individuals whose kidney disease is linked to diabetes or lupus, where MSC research has been most active.
Transplant Recipients & Candidates
People interested in research on reducing transplant rejection and long-term immunosuppression.
Is Regenerative Treatment Right for You?
A specialist medical evaluation, including a review of kidney function and the underlying cause, should always come first.
The Journey of Kidney Disease Research
From Understanding Kidney Damage to Cell-Based Research
Understanding Kidney Function
Research established how the kidneys filter blood and why lost filtering units do not regrow.
Understanding Fibrosis
Scientists identified inflammation and scarring as central drivers of progressive kidney disease.
Early MSC Studies
Small clinical studies began testing MSCs in diabetic kidney disease, lupus nephritis and transplantation.
Kidney Organoids & Future Research
Researchers now grow mini-kidney structures from stem cells to study disease and explore future therapies.
Ready to Learn More?
Kidney disease research continues to evolve, but early findings are not yet proof of benefit. Understanding what has been studied can help you make informed decisions alongside your nephrologist.
Hear From the Experts Advancing Kidney Research
Professor Interviews
Hear a leading kidney stem cell scientist discuss the prospects for regenerating diseased kidneys.
Documentaries
Explore laboratory research using human stem cells to understand and treat kidney disease.
Medical Podcasts
Listen to researchers discuss how stem cell-derived kidney organoids are used to study kidney disease.
Patient Perspectives
Understand the applications and current challenges of stem cell-derived kidney tissue.
Continue the Conversation
Kidney disease research is progressing, but no regenerative therapy has yet been shown to restore lost kidney function. Understanding the evidence and regulatory status of a treatment is an important part of making an informed decision.
Questions patients ask before applying
Can stem cells reverse kidney damage?
No trial has shown that stem cell therapy reverses established kidney damage. Research is investigating whether MSCs can slow inflammation and scarring.
What types of kidney disease are being studied?
MSC research has focused mainly on diabetic kidney disease, lupus nephritis and kidney transplantation, with smaller studies in other forms of chronic kidney disease.
Can stem cell therapy replace dialysis?
No. Dialysis and transplantation remain the established treatments for kidney failure. Regenerative approaches are being studied as possible additions to care, not replacements.
How are stem cells used in kidney transplantation research?
Researchers are studying whether MSCs given around the time of transplant can reduce rejection and allow lower doses of immunosuppressive medication.
Is stem cell therapy approved for chronic kidney disease?
Approval depends on the specific therapy and country. Patients should always verify the regulatory status of any proposed treatment.
Should I continue my current kidney treatment?
Yes. Blood pressure control, diabetes management and prescribed medications remain essential. Any change should be discussed with your nephrologist.